Neutrophil glucose flux as a therapeutic target in antiphospholipid syndrome-Reference-Cited by-同舟云学术

Neutrophil glucose flux as a therapeutic target in antiphospholipid syndrome

Published:2024-06-13 Issue:15 Volume:134 Page:
ISSN:1558-8238
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Tambralli Ajay,Harbaugh Alyssa,NaveenKumar Somanathapura K.,Radyk Megan D.,Rysenga Christine E.^ORCID,Sabb Kaitlyn,Hurley Julia M.^ORCID,Sule Gautam J.,Yalavarthi Srilakshmi,Estes Shanea K.,Hoy Claire K.,Smith Tristin,Sarosh Cyrus,Madison Jacqueline A.^ORCID,Schaefer Jordan K.,Sood Suman L.,Zuo Yu,Sawalha Amr H.^ORCID,Lyssiotis Costas A.^ORCID,Knight Jason S.^ORCID

Funder

Rheumatology Research Foundation

University of Michigan

National Institutes of Health

National Cancer Institute

Publisher

American Society for Clinical Investigation

Link

https://www.jci.org/articles/view/169893/files/pdf

Reference84 articles.

1. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

2. The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria

3. EULAR recommendations for the management of antiphospholipid syndrome in adults

4. Recurrent thrombosis in patients with antiphospholipid antibodies and arterial thrombosis on antithrombotic therapy

5. Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTION International Clinical Database and Repository

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular metabolism changes in atherosclerosis and the impact of comorbidities;Frontiers in Cell and Developmental Biology;2024-08-12